The relative levels of these adipokines are such that they adversely affect insulin sensitivity; adiponectin improves insulin signaling, while resistin blocks it, thus leading to insulin resistance and facilitating the progression from MASLD to T2DM (193). This evidence concerns the gene INS and Insulin resistance.